RXRX
STRONGRECURSION PHARMACEUTICALS, INC.
CIK: 0001601830
Last activity: 1 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (4 total, 4 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Borgeson Blake
DIRECTOR
|
0 | 3 | -$2.47M |
6,259,863 shares
$21.66M
|
|
Gibson Christopher
DIRECTOR
|
0 | 7 | -$1.15M |
906,556 shares
$2.95M
|
|
Khan Najat
CEO and President
|
0 | 2 | -$643K |
2,262,085 shares
$7.57M
|
|
Taylor Ben R
Chief Financial Officer
|
0 | 3 | -$158K |
1,180,318 shares
$4.00M
|
Recent Transactions
40,000 shares @ $3.25
$130K
Mar 23, 2026
7,956 shares @ $3.39
$27K
Mar 17, 2026
28,298 shares @ $3.35
$95K
Mar 9, 2026
170,000 shares @ $3.46
$588K
Mar 3, 2026
40,000 shares @ $3.46
$138K
Feb 19, 2026
13,426 shares @ $3.08
$41K
Feb 18, 2026
40,000 shares @ $4.12
$165K
Feb 4, 2026
220,000 shares @ $4.20
$924K
Feb 3, 2026
40,000 shares @ $4.47
$179K
Jan 20, 2026
220,000 shares @ $4.36
$959K
Jan 6, 2026
40,000 shares @ $4.25
$170K
Jan 5, 2026
21,383 shares @ $4.18
$89K
Dec 29, 2025
124,403 shares @ $4.41
$549K
Dec 22, 2025
40,000 shares @ $4.50
$180K
Dec 19, 2025
40,000 shares @ $4.63
$185K
Dec 4, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.